Biomarkers in Medicine · 2019 · 16 citations · 23 references
MedicineMolecular BiologyMolecular GeneticsEpigeneticsGene ExpressionTranscriptional RegulationDna Methylation ProfilingEpigenetic Biomarker DiscoveryHepatocellular CarcinomaLiver CancerLiver DiseaseViral HepatitisChronic Hepatitis B - Associated CarcinomaChronic Viral HepatitisMethylation DetectionNatural Killer Cell Receptor Nkg2dPositive Predictive ValuePromoter MethylationPromoter Methylation AnalysisReal-time Polymerase Chain Reaction (Pcr)
Aim: Natural killer cell receptor group 2D (NKG2D) plays an important role in the immune regulation of tumors. We speculate that DNA methylation are involved in the regulation of NKG2D gene. Methods: We investigated the methylation status of the NKG2D promoter in peripheral blood mononuclear cells of hepatocellular carcinoma (HCC) patients, chronic hepatitis B patients and healthy controls by methylation-specific PCR and the mRNA expression level was examined by real-time quantitative PCR. Results: The methylation frequency of NKG2D promoter in HCC patients was higher than that of chronic hepatitis B patients and healthy controls. NKG2D promoter methylation has a good predictive value for HCC diagnosis. Conclusion: NKG2D promoter methylation can be used as a noninvasive marker for detecting HCC.
23
Management of Hepatocellular Carcinoma: An Update Δσ
Jordi Bruix, Morris Sherman · Hepatology · 2011 · 8.1K citations · Full text
Chronic hepatitis B: Update 2009 #
Anna S. Lok, Brian J. McMahon · Hepatology · 2009 · 2.8K citations · Full text
DNA methylation‐based prognosis and epidrivers in hepatocellular carcinoma
Augusto Villanueva, Anna Portela, Sergi Sayols et al. · Hepatology · 2015 · 446 citations · Full text
NKG2D ligands as therapeutic targets.
Paul W. Spear, Ming-Ru Wu, Marie-Louise Sentman et al. · PubMed · 2013 · 219 citations · Full text
Life Sciences, Immunology, Oncology +13